Trials / Completed
CompletedNCT06764992
Exploring Men s Prostate Cancer Genetic Risk Perceptions
Exploring Men s Prostate Cancer Genetic Risk Perceptions and Willingness to Give a Biospecimen for Genetic Risk Testing
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs among unaffected men of diverse races/ethnicities who are considering undergoing prostate cancer screening and their willingness of men to provide a biospecimen (saliva sample) and test the samples for prostate cancer aggressiveness and determine risk category based on SNP genetic profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | Participants will be asked to complete a questionnaire on demographics, risk beliefs and perception and prostate cancer screening behaviors, intentions and awareness of informed decision making. |
| OTHER | Saliva Sample | Participants will be asked to provide a saliva sample for genetic risk testing to generate a SNP risk profile using a saliva sample collection kit with collection, storage and mailing instructions. We will assess the proportion of consented men who will provide a saliva sample. |
Timeline
- Start date
- 2022-08-25
- Primary completion
- 2024-04-20
- Completion
- 2024-06-07
- First posted
- 2025-01-09
- Last updated
- 2026-02-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06764992. Inclusion in this directory is not an endorsement.